In our study, fasting and postprandial GLP-1 levels were remarkably improved at 6 and 12 months, and they were most probably the main culprits that led to optimal glycemic control and T2DM remission in the study cohort. The gene discussed is GCG; the disease is type 2 diabetes mellitus.